HDAX Therapeutics

Developing innovative small molecules targeting HDAC6 for neurology and cardiometabolic diseases.

HQ location

Toronto, Canada

Website

Launch date

Aug 2021

Employees

Enterprise value

$13—19m

https://twitter.com/hdaxtx https://www.linkedin.com/company/hdaxtx

biotechnology

Authorizing premium user...